Skip to content

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

USD/JPY likely to reverse after recent rebound

USD/JPY looks likely to reverse lower despite seeing a strong rise in early trade.

Source: Bloomberg

USD/JPY support could fade despite todays rise

The USD/JPY positivity seen over the back-end of September has started to wane, with Friday seeing sharp downside after Donald Trump contracted Covid-19. Looking at things from a wider perspective, the downtrend we have seen over the course of the year looks likely to come back into play once more before long. A rise through the 106.55 resistance level would negate that trend, but until that happens, it looks likely we will see this current rise falter once more. With a confluence of trendline and 61.8% Fib resistance coming into play here, traders should keep a close eye on this pair.

Source: ProRealTime

From an intraday perspective, we have seen the pair claw its way back into the 200-SMA (4hr) today. With that wider bearish trend in play, and Friday price action having broken the recent short-term rally, there is a good chance this recent rise will be brief in nature. As such, a bearish outlook is in play here, with a break through the 105.80 swing-high required to bring an end to this current bearish short-term outlook.

Source: ProRealTime

Related articles

Live prices on most popular markets

  • Equities
  • Indices
  • Forex
  • Commodities
website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

" >


Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Monday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.


You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.


This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.